Press release
RNA Based Therapeutic Market 2023 Trends: Expected to Grow at a CAGR of 17.6% by 2030, Claims AMR
RNA Based Therapeutic Market
Key Takeaways:
Rapid Growth: The RNA-based therapeutic market has experienced significant growth in recent years. This can be attributed to advancements in RNA technologies, increased understanding of disease mechanisms, and successful clinical trials of RNA-based drugs.
mRNA Vaccines: The COVID-19 pandemic has propelled the development and adoption of mRNA vaccines, such as the Pfizer-BioNTech and Moderna vaccines. These vaccines have demonstrated high efficacy in preventing COVID-19 and have brought mRNA therapeutics into the spotlight.
Gene Silencing: RNA-based therapeutics are being used for gene silencing to treat various diseases. Small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) are designed to target specific RNA molecules and inhibit their expression, providing potential treatments for conditions like genetic disorders, cancers, and viral infections.
RNA Interference (RNAi): RNAi is a biological process that regulates gene expression by silencing target genes through the degradation of specific RNA molecules. This mechanism has been harnessed to develop RNA-based therapeutics that can selectively inhibit disease-causing genes, showing promise in treating genetic disorders and certain types of cancers.
Rare Diseases: RNA-based therapies have demonstrated significant potential in addressing rare diseases. These therapies can target specific genetic mutations responsible for rare disorders and offer personalized treatment options for patients with limited treatment choices.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546
Market Drivers:
Advancements in RNA Technologies: Rapid advancements in RNA technologies, such as mRNA synthesis, RNA interference (RNAi), and antisense oligonucleotides (ASOs), have expanded the possibilities for developing RNA-based therapeutics. These advancements have improved the stability, delivery, and specificity of RNA molecules, increasing their therapeutic potential.
Precision Medicine and Personalized Treatments: RNA-based therapeutics offer the potential for precise targeting of disease-causing genes or specific mutations. This personalized approach allows for tailored treatments based on an individual's genetic profile, leading to more effective and targeted therapies for various diseases, including rare genetic disorders.
Market Segmentation:
Therapeutic Modality:
a. mRNA Therapeutics: This segment includes mRNA-based therapies, such as mRNA vaccines, which encode specific proteins to elicit an immune response or deliver therapeutic molecules.
b. RNA Interference (RNAi): This segment encompasses RNAi-based therapeutics that utilize small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) to silence or knockdown specific disease-causing genes.
c. Antisense Oligonucleotides (ASOs): ASOs are synthetic RNA molecules designed to bind to specific RNA targets and modulate gene expression, either by blocking translation or promoting degradation.
d. Others: This segment includes other RNA-based therapeutic modalities, such as aptamers or ribozymes, which have unique mechanisms of action.
Indication:
a. Infectious Diseases: This segment includes RNA-based therapeutics targeting viral or bacterial infections, such as mRNA vaccines for COVID-19 or RNA-based antiviral therapies.
b. Genetic Disorders: RNA-based therapeutics can target specific genetic mutations responsible for inherited diseases, including rare genetic disorders.
c. Cancer: RNA-based therapeutics are being developed to selectively target cancer cells or inhibit specific oncogenes, potentially offering personalized treatment options.
d. Neurological Disorders: This segment focuses on RNA-based therapies for neurological conditions like Alzheimer's disease, Parkinson's disease, or amyotrophic lateral sclerosis (ALS).
e. Cardiovascular Disorders: RNA-based therapeutics targeting cardiovascular diseases, such as atherosclerosis or heart failure, fall under this segment.
End User:
a. Hospitals and Clinics: RNA-based therapeutics may be administered in hospital or clinical settings, particularly for acute conditions or advanced therapies.
b. Research Institutes: Academic and research institutions play a crucial role in developing and studying RNA-based therapeutics.
c. Pharmaceutical and Biotechnology Companies: This segment includes companies involved in the research, development, and commercialization of RNA-based therapies.
Geography:
The market can also be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, as the adoption and regulatory landscape for RNA-based therapeutics may vary across different regions.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/546
Competitive Landscape:
Silence Therapeutics plc.
Arbutus Biopharma Corporation
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals, Inc.
Benitec Biopharma Inc.
Genzyme (Sanofi), Arrowhead Pharmaceuticals
Biogen, Inc.
Gradalis, Inc.
Procure Complete Report at 20% Discount (258 Pages):
https://www.alliedmarketresearch.com/purchase-enquiry/546
Related Reports :
Body Composition Analyzers Market: https://www.alliedmarketresearch.com/body-composition-analyzers-market
Syringes Market: https://www.alliedmarketresearch.com/syringes-market-A07514
Medical Aesthetic Devices Market: https://www.alliedmarketresearch.com/medical-aesthetics-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Based Therapeutic Market 2023 Trends: Expected to Grow at a CAGR of 17.6% by 2030, Claims AMR here
News-ID: 3135333 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
